Apyx Medical Debt to Equity Ratio 2010-2024 | APYX
Current and historical debt to equity ratio values for Apyx Medical (APYX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Apyx Medical debt/equity for the three months ending December 31, 2024 was 2.37.
| Apyx Medical Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-12-31 | $0.05B | $0.01B | 3.52 |
| 2024-09-30 | $0.05B | $0.01B | 4.42 |
| 2024-06-30 | $0.05B | $0.02B | 3.38 |
| 2024-03-31 | $0.05B | $0.02B | 2.46 |
| 2023-12-31 | $0.05B | $0.03B | 1.94 |
| 2023-09-30 | $0.03B | $0.03B | 0.77 |
| 2023-06-30 | $0.03B | $0.04B | 0.70 |
| 2023-03-31 | $0.02B | $0.04B | 0.57 |
| 2022-12-31 | $0.01B | $0.04B | 0.37 |
| 2022-09-30 | $0.01B | $0.04B | 0.31 |
| 2022-06-30 | $0.01B | $0.05B | 0.29 |
| 2022-03-31 | $0.01B | $0.05B | 0.26 |
| 2021-12-31 | $0.02B | $0.05B | 0.27 |
| 2021-09-30 | $0.01B | $0.06B | 0.24 |
| 2021-06-30 | $0.01B | $0.06B | 0.21 |
| 2021-03-31 | $0.01B | $0.06B | 0.18 |
| 2020-12-31 | $0.01B | $0.06B | 0.16 |
| 2020-09-30 | $0.01B | $0.06B | 0.17 |
| 2020-06-30 | $0.01B | $0.07B | 0.16 |
| 2020-03-31 | $0.01B | $0.07B | 0.17 |
| 2019-12-31 | $0.01B | $0.07B | 0.19 |
| 2019-09-30 | $0.01B | $0.08B | 0.13 |
| 2019-06-30 | $0.01B | $0.08B | 0.10 |
| 2019-03-31 | $0.01B | $0.08B | 0.11 |
| 2018-12-31 | $0.01B | $0.09B | 0.10 |
| 2018-09-30 | $0.02B | $0.09B | 0.25 |
| 2018-06-30 | $0.01B | $0.02B | 0.42 |
| 2018-03-31 | $0.01B | $0.02B | 0.40 |
| 2017-12-31 | $0.01B | $0.02B | 0.41 |
| 2017-09-30 | $0.01B | $0.02B | 0.36 |
| 2017-06-30 | $0.01B | $0.02B | 0.38 |
| 2017-03-31 | $0.01B | $0.03B | 0.34 |
| 2016-12-31 | $0.01B | $0.03B | 0.34 |
| 2016-09-30 | $0.01B | $0.02B | 0.41 |
| 2016-06-30 | $0.01B | $0.02B | 0.39 |
| 2016-03-31 | $0.01B | $0.02B | 0.38 |
| 2015-12-31 | $0.01B | $0.02B | 0.34 |
| 2015-09-30 | $0.01B | $0.03B | 0.35 |
| 2015-06-30 | $0.01B | $0.03B | 0.31 |
| 2015-03-31 | $0.01B | $0.03B | 0.32 |
| 2014-12-31 | $0.02B | $0.01B | 4.29 |
| 2014-09-30 | $0.02B | $0.01B | 2.20 |
| 2014-06-30 | $0.02B | $0.01B | 1.57 |
| 2014-03-31 | $0.02B | $0.01B | 1.75 |
| 2013-12-31 | $0.01B | $0.02B | 0.56 |
| 2013-09-30 | $0.01B | $0.02B | 0.29 |
| 2013-06-30 | $0.01B | $0.02B | 0.29 |
| 2013-03-31 | $0.01B | $0.02B | 0.25 |
| 2012-12-31 | $0.01B | $0.02B | 0.23 |
| 2012-09-30 | $0.01B | $0.02B | 0.24 |
| 2012-06-30 | $0.01B | $0.02B | 0.25 |
| 2012-03-31 | $0.01B | $0.02B | 0.25 |
| 2011-12-31 | $0.01B | $0.02B | 0.28 |
| 2011-09-30 | $0.01B | $0.02B | 0.26 |
| 2011-06-30 | $0.01B | $0.02B | 0.27 |
| 2011-03-31 | $0.01B | $0.02B | 0.27 |
| 2010-12-31 | $0.01B | $0.02B | 0.28 |
| 2010-09-30 | $0.01B | $0.02B | 0.27 |
| 2010-06-30 | $0.01B | $0.02B | 0.26 |
| 2010-03-31 | $0.01B | $0.02B | 0.32 |
| 2009-12-31 | $0.01B | $0.02B | 0.31 |
| 2009-09-30 | $0.01B | $0.02B | 0.40 |
| 2009-06-30 | $0.01B | $0.02B | 0.42 |
| 2009-03-31 | $0.01B | $0.02B | 0.38 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.037B | $0.048B |
| Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly known as Bovie Medical Corporation, is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.162B | 27.40 |
| Boston Scientific (BSX) | United States | $140.689B | 37.90 |
| Stryker (SYK) | United States | $132.255B | 28.42 |
| EssilorLuxottica (ESLOY) | France | $128.431B | 0.00 |
| Medtronic (MDT) | Ireland | $105.938B | 15.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.424B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.151B | 26.20 |
| ResMed (RMD) | United States | $31.269B | 24.08 |
| Agilent Technologies (A) | United States | $29.217B | 19.30 |
| GE HealthCare Technologies (GEHC) | United States | $28.556B | 13.89 |
| Terumo (TRUMY) | Japan | $28.160B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.192B | 15.85 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.373B | 12.24 |
| Insulet (PODD) | United States | $17.332B | 74.11 |
| Baxter (BAX) | United States | $14.818B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.356B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.938B | 17.06 |
| Bio-Rad Laboratories (BIO) | United States | $6.672B | 23.10 |
| Demant (WILYY) | Denmark | $6.644B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.977B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.455B | 9.89 |
| ICU Medical (ICUI) | United States | $3.400B | 29.07 |
| Haemonetics (HAE) | United States | $2.872B | 13.52 |
| Envista Holdings (NVST) | United States | $2.614B | 20.80 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 14.75 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 44.47 |
| QuidelOrtho (QDEL) | United States | $1.698B | 14.22 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.214B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.189B | 18.67 |
| AdaptHealth (AHCO) | United States | $1.051B | 10.12 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 8.67 |
| Neogen (NEOG) | United States | $0.953B | 12.19 |
| Phibro Animal Health (PAHC) | United States | $0.700B | 10.74 |
| Evolus (EOLS) | United States | $0.686B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.649B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Owens & Minor (OMI) | United States | $0.535B | 4.56 |
| CeriBell (CBLL) | United States | $0.532B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Omeros (OMER) | United States | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.368B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.302B | 13.07 |
| Viemed Healthcare (VMD) | United States | $0.262B | 23.68 |
| Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.65 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.251B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 44.40 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Biote (BTMD) | United States | $0.181B | 4.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.175B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.24 |
| Brainsway (BWAY) | Israel | $0.155B | 48.47 |
| Jin Medical (ZJYL) | China | $0.147B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.42 |
| Agape ATP (ATPC) | $0.094B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Veru (VERU) | United States | $0.078B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.65 |
| Zynex (ZYXI) | United States | $0.066B | 24.22 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 11.61 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 51.50 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |